This HTML5 document contains 144 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n11http://dx.doi.org/10.2147/

Statements

Subject Item
wd:Q37269725
rdf:type
wikibase:Item
schema:description
artículu científicu espublizáu en 2016 article científic teaduslik artikkel مقالة علمية نشرت في 15 سبتمبر 2016 2016年学术文章 บทความทางวิทยาศาสตร์ artículo científico publicado en 2016 2016年学术文章 artykuł naukowy vedecký článok artikull shkencor επιστημονικό άρθρο 2016年學術文章 научни чланак სამეცნიერო სტატია artigo científico مقالهٔ علمی מאמר מדעי article scientifique publié en 2016 vitenskapelig artikkel wetenschappelijk artikel mokslinis straipsnis 2016年学术文章 научная статья 2016년 논문 artigo científico (publicado na 2016) 2016年學術文章 2016年学术文章 2016年学术文章 vědecký článek scienca artikolo bài báo khoa học мақолаи илмӣ articol științific наукова стаття, опублікована у вересні 2016 գիտական հոդված scientific article published on 15 September 2016 videnskabelig artikel (udgivet 2016) 2016年學術文章 wissenschaftlicher Artikel научна статия 2016年の論文 artigo científico (publicado na 2016) article scientific научни чланак 2016 nî lūn-bûn artikulong pang-agham 2016年學術文章 2016年學術文章 bilimsel makale tudományos cikk سائنسی مضمون ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ мақолаи илмӣ vetenskaplig artikel tieteellinen artikkeli naučni članak articolo scientifico vitskapeleg artikkel 2016年學術文章
p:P577
wds:Q37269725-92149056-4D7D-4646-9609-A07A3073B1D2
wdt:P577
2016-09-15T00:00:00Z
p:P407
wds:Q37269725-0F3497A8-4959-472F-A5BC-07C03179A974
wdt:P407
wd:Q1860
p:P2860
wds:Q37269725-5E743E71-B4DA-4B66-BB1E-95110242D48A wds:Q37269725-62ECE37F-3DC9-4E3C-AF4F-25D2833EA7EB wds:Q37269725-2DA46CDD-AEA9-4F49-A964-C9D1A97931E9 wds:Q37269725-2F946F5A-06B0-436C-983E-C4E042FAEA9B wds:Q37269725-34BB5B3F-CCEA-4C74-828F-09A93C809EA6 wds:Q37269725-40030347-B871-4A34-A2DA-671F36C7EC7F wds:Q37269725-5780274A-3FD4-4428-9B29-077593A471D5 wds:Q37269725-5B1280FC-68A6-4B5F-98FB-EC76827B3659 wds:Q37269725-C56736B4-17E0-46D8-A6F1-D7E113BADD54 wds:Q37269725-CEEEBA3A-0BD9-45EF-B877-948417BC97F6 wds:Q37269725-F86FB5C4-7B65-4BBB-9937-48D6D160FDCA wds:Q37269725-F8CA7EAC-1437-4115-8249-0FE1CE986AD2 wds:Q37269725-9242521F-9AF3-460C-A63F-EB68D51B94BB wds:Q37269725-9AA81585-7D32-4069-9CE1-6D81BF3AE0EF wds:Q37269725-B4FFD387-4BC7-4014-865D-5987D727FBE8 wds:Q37269725-B63A3973-B12A-4DFA-B3B5-079FE8909400 wds:Q37269725-2537376C-7A34-4599-89B9-65FF60FD9C4C wds:Q37269725-25DCB0D3-A7E1-4EF7-8183-07736A66A8AF
wdt:P2860
wd:Q42626230 wd:Q28300494 wd:Q34470246 wd:Q38079343 wd:Q41962966 wd:Q43973045 wd:Q24202483 wd:Q35159391 wd:Q24200612 wd:Q46812006 wd:Q43227720 wd:Q24234457 wd:Q37932165 wd:Q87208545 wd:Q39208801 wd:Q45055692 wd:Q77362629 wd:Q71939893
p:P2093
wds:Q37269725-E9ACFA9D-FFC9-43E9-B0FF-218ADCDC2BDF wds:Q37269725-91251F83-4CFD-4AC0-AC44-DA8099F5462D wds:Q37269725-6B5095E2-7C29-46B7-9052-20B8FA65D952 wds:Q37269725-6DB21EA1-D6DA-48AD-8C66-7C22AA710F55
wdt:P2093
Marco Serrani Paula Briggs Susanne Parke Kai Vogtländer
rdfs:label
Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r
skos:prefLabel
Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r
schema:name
Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r
p:P1476
wds:Q37269725-921444B9-F704-4D72-8997-7C36035ADED8
wdt:P1476
Continuation rates, bleeding profile acceptability, and satisfaction of women using an oral contraceptive pill containing estradiol valerate and dienogest versus a progestogen-only pill after switching from an ethinylestradiol-containing pill in a r
p:P304
wds:Q37269725-22D2902C-81FA-4E34-8B71-55DE0BF27231
wdt:P304
477-487
p:P31
wds:Q37269725-E0827C81-499B-4B70-8A47-E2A9415B98FA
wdt:P31
wd:Q13442814
p:P921
wds:Q37269725-6F65D4DC-2658-4F86-A043-87B258C5BB83 wds:Q37269725-E28973E3-3673-42C2-918A-19E0479126E2
wdt:P921
wd:Q817281 wd:Q5401768
p:P698
wds:Q37269725-A9D26442-5858-4FCF-8FD1-99652A247E94
wdtn:P698
n12:27695365
wdt:P698
27695365
p:P1433
wds:Q37269725-4906ECAE-7AB9-475C-83FB-517920298AE3
wdt:P1433
wd:Q6051629
p:P478
wds:Q37269725-AB80DF8A-813C-4F9E-8DFD-D1620BDC758F
wdt:P478
8
p:P356
wds:Q37269725-BB232394-B5D4-4B0F-BE55-4D4B4D415819
wdtn:P356
n11:IJWH.S107586
wdt:P356
10.2147/IJWH.S107586
p:P275
wds:Q37269725-56380a95-a936-4f31-bac8-724dcfe6b686
p:P6216
wds:Q37269725-bd29cce8-ffec-4fb9-90e9-cb088428ee25
wdt:P275
wd:Q18810331
wdt:P6216
wd:Q50423863
p:P932
wds:Q37269725-BF19BD65-D179-4C60-9C11-904225300054
wdt:P932
5029837